MCMedicalCodingSoftware
065B0ZZ

065B0ZZ: Destruction of Left Renal Vein, Open Approach

Billable / specific codeICD-10-PCS

CMS abbreviated title: Destruction of Left Renal Vein, Open Approach

How 065B0ZZ is built

Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.

  1. 0SectionMedical and Surgical: What family of procedure this is
  2. 6Body systemWhich system it acts on
  3. 5Root operationThe objective: the verb of the procedure
  4. BBody partThe specific site
  5. 0ApproachHow the site was reached
  6. ZDeviceWhat was left in place, if anything
  7. ZQualifierA further distinction where one applies

Codes near 065B0ZZ

In CMS’s own ordering, which groups codes that differ by only the last character or two, usually the approach, device or qualifier.

  • 06573ZZDestruction of Colic Vein, Percutaneous Approach
  • 06574ZZDestruction of Colic Vein, Percutaneous Endoscopic Approach
  • 06580ZZDestruction of Portal Vein, Open Approach
  • 06583ZZDestruction of Portal Vein, Percutaneous Approach
  • 06584ZZDestruction of Portal Vein, Percutaneous Endoscopic Approach
  • 06590ZZDestruction of Right Renal Vein, Open Approach
  • 06593ZZDestruction of Right Renal Vein, Percutaneous Approach
  • 06594ZZDestruction of Right Renal Vein, Percutaneous Endoscopic Approach
  • 065B0ZZDestruction of Left Renal Vein, Open Approach
  • 065B3ZZDestruction of Left Renal Vein, Percutaneous Approach
  • 065B4ZZDestruction of Left Renal Vein, Percutaneous Endoscopic Approach
  • 065C0ZZDestruction of Right Common Iliac Vein, Open Approach
  • 065C3ZZDestruction of Right Common Iliac Vein, Percutaneous Approach
  • 065C4ZZDestruction of Right Common Iliac Vein, Percutaneous Endoscopic Approach
  • 065D0ZZDestruction of Left Common Iliac Vein, Open Approach
  • 065D3ZZDestruction of Left Common Iliac Vein, Percutaneous Approach
  • 065D4ZZDestruction of Left Common Iliac Vein, Percutaneous Endoscopic Approach
ICD-10-PCSFY2027